Previous 10 | Next 10 |
Gainers: ThermoGenesis (NASDAQ: THMO ) +82% . More news on: ThermoGenesis Holdings, Inc., Summer Infant, Inc., Midatech Pharma plc, Stocks on the move, , Read more ...
LMP Automotive Holdings (NASDAQ: LMPX ) +35% . More news on: LMP Automotive Holdings, Inc., AgEagle Aerial Systems, Inc., Soligenix, Inc., Stocks on the move, , Read more ...
Marker Therapeutics (NASDAQ: MRKR ) is up 20.3% after hours (adding to regular-session gains of 14.7% ) after confirming it received FDA Orphan Drug Designation for its therapy for acute myeloid leukemia. More news on: Marker Therapeutics, Inc., Healthcare stocks news, Stocks on the m...
Gainers: MRKR +24.2% . ORN +22.7% . UCTT +14.7% . HLX +14.2% . AR +12.2% . More news on: Marker Therapeutics, Inc., Orion Group Holdings, Inc., Ultra Clean Holdings, Inc., Stocks on the move, , Read more ...
HOUSTON , April 29, 2020 /PRNewswire/ -- Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, toda...
Gainers: MRKR +15.1% . ARAY +14.9% . BXMT +8.4% . INO +7.6% . PAA +6.2% . More news on: Marker Therapeutics, Inc., Accuray Incorporated, Blackstone Mortgage Trust, Inc., Stocks on the move, , Read more ...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Marker Therapeutics (NASDAQ: MRKR ): FY GAAP EPS of -$0.47 beats by $0.02 . Revenue of $0.21M (+5.0% Y/Y) Press Release More news on: Marker Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, ,
HOUSTON , March 12, 2020 /PRNewswire/ -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications,...
Sprint (NYSE: S ) +74% after judge approves T-Mobile merger . More news on: Sprint Corporation, Rexahn Pharmaceuticals, Inc., ZK International Group Co., Ltd., Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Marker Therapeutics Inc. Company Name:
MRKR Stock Symbol:
NASDAQ Market:
Marker Therapeutics Inc. Website:
Preliminary safety and efficacy with sustained objective responses observed in patients with lymphoma treated with MT-601 in Phase 1 APOLLO study Study participant with Non-Hodgkin’s Lymphoma who relapsed within 90 days of anti-CD19 CAR T cell therapy remains in complete response...
Preliminary data from study in patients with lymphoma enrolled at City of Hope National Medical Center was presented at the 11 th Global Summit on Hematologic Malignancies in Whistler, BC, Canada Study participants tolerated initial dose level well and demonstrated durab...